Homo sapiens Protein: MAPT | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||
InnateDB Protein | IDBP-55169.7 | ||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||
Gene Symbol | MAPT | ||||||||||||||||||||||
Protein Name | microtubule-associated protein tau | ||||||||||||||||||||||
Synonyms | DDPAC; FTDP-17; MAPTL; MSTD; MTBT1; MTBT2; PPND; PPP1R103; TAU; | ||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||
Ensembl Protein | ENSP00000303214 | ||||||||||||||||||||||
InnateDB Gene | IDBG-55163 (MAPT) | ||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||
Function | Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N- terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization. {ECO:0000269PubMed:21985311}. | ||||||||||||||||||||||
Subcellular Localization | Cytoplasm, cytosol {ECO:0000269PubMed:10747907}. Cell membrane {ECO:0000269PubMed:10747907}; Peripheral membrane protein {ECO:0000269PubMed:10747907}; Cytoplasmic side {ECO:0000269PubMed:10747907}. Cytoplasm, cytoskeleton {ECO:0000269PubMed:10747907}. Cell projection, axon {ECO:0000269PubMed:10747907}. Note=Mostly found in the axons of neurons, in the cytosol and in association with plasma membrane components. | ||||||||||||||||||||||
Disease Associations | Note=In Alzheimer disease, the neuronal cytoskeleton in the brain is progressively disrupted and replaced by tangles of paired helical filaments (PHF) and straight filaments, mainly composed of hyperphosphorylated forms of TAU (PHF-TAU or AD P- TAU). O-GlcNAcylation is greatly reduced in Alzheimer disease brain cerebral cortex leading to an increase in TAU/MAPT phosphorylations. {ECO:0000269PubMed:14517953}.Frontotemporal dementia (FTD) [MIM:600274]: A form of dementia characterized by pathologic finding of frontotemporal lobar degeneration, presenile dementia with behavioral changes, deterioration of cognitive capacities and loss of memory. In some cases, parkinsonian symptoms are prominent. Neuropathological changes include frontotemporal atrophy often associated with atrophy of the basal ganglia, substantia nigra, amygdala. In most cases, protein tau deposits are found in glial cells and/or neurons. {ECO:0000269PubMed:10208578, ECO:0000269PubMed:10214944, ECO:0000269PubMed:10489057, ECO:0000269PubMed:10553987, ECO:0000269PubMed:10802785, ECO:0000269PubMed:11071507, ECO:0000269PubMed:11117541, ECO:0000269PubMed:11585254, ECO:0000269PubMed:11889249, ECO:0000269PubMed:11921059, ECO:0000269PubMed:12473774, ECO:0000269PubMed:12509859, ECO:0000269PubMed:15883319, ECO:0000269PubMed:16240366, ECO:0000269PubMed:9629852, ECO:0000269PubMed:9641683, ECO:0000269PubMed:9736786, ECO:0000269PubMed:9789048, ECO:0000269PubMed:9973279}. Note=The disease is caused by mutations affecting the gene represented in this entry.Pick disease of the brain (PIDB) [MIM:172700]: A rare form of dementia pathologically defined by severe atrophy, neuronal loss and gliosis. It is characterized by the occurrence of tau-positive inclusions, swollen neurons (Pick cells) and argentophilic neuronal inclusions known as Pick bodies that disproportionally affect the frontal and temporal cortical regions. Clinical features include aphasia, apraxia, confusion, anomia, memory loss and personality deterioration. {ECO:0000269PubMed:10604746, ECO:0000269PubMed:11089577, ECO:0000269PubMed:11117542, ECO:0000269PubMed:11601501, ECO:0000269PubMed:11891833}. Note=The disease is caused by mutations affecting the gene represented in this entry.Note=Defects in MAPT are a cause of corticobasal degeneration (CBD). It is marked by extrapyramidal signs and apraxia and can be associated with memory loss. Neuropathologic features may overlap Alzheimer disease, progressive supranuclear palsy, and Parkinson disease.Progressive supranuclear palsy 1 (PSNP1) [MIM:601104]: Characterized by akinetic-rigid syndrome, supranuclear gaze palsy, pyramidal tract dysfunction, pseudobulbar signs and cognitive capacities deterioration. Neurofibrillary tangles and gliosis but no amyloid plaques are found in diseased brains. Most cases appear to be sporadic, with a significant association with a common haplotype including the MAPT gene and the flanking regions. Familial cases show an autosomal dominant pattern of transmission with incomplete penetrance; genetic analysis of a few cases showed the occurrence of tau mutations, including a deletion of Asn-613. {ECO:0000269PubMed:10534245, ECO:0000269PubMed:11220749, ECO:0000269PubMed:12325083, ECO:0000269PubMed:14991828, ECO:0000269PubMed:14991829, ECO:0000269PubMed:16157753}. Note=The disease is caused by mutations affecting the gene represented in this entry.Parkinson-dementia syndrome (PARDE) [MIM:260540]: A syndrome characterized by parkinsonism, tremor, rigidity, dementia, ophthalmoparesis and pyramidal signs. Neurofibrillary degeneration occurs in the hippocampus, basal ganglia and brainstem nuclei. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||||
Tissue Specificity | Expressed in neurons. Isoform PNS-tau is expressed in the peripheral nervous system while the others are expressed in the central nervous system. | ||||||||||||||||||||||
Comments | |||||||||||||||||||||||
Interactions | |||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 129 experimentally validated interaction(s) in this database.
They are also associated with 10 interaction(s) predicted by orthology.
|
||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||
InterPro |
IPR001084
Microtubule associated protein, tubulin-binding repeat IPR002955 Microtubule-associated protein Tau |
||||||||||||||||||||||
PFAM |
PF00418
|
||||||||||||||||||||||
PRINTS |
PR01261
|
||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||
SMART | |||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||
Modification | |||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||
SwissProt | P10636 | ||||||||||||||||||||||
PhosphoSite | PhosphoSite-P10636 | ||||||||||||||||||||||
TrEMBL | A0A024RA17 | ||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||
Entrez Gene | 4137 | ||||||||||||||||||||||
UniGene | Hs.101174 | ||||||||||||||||||||||
RefSeq | NP_005901 | ||||||||||||||||||||||
HUGO | HGNC:6893 | ||||||||||||||||||||||
OMIM | 157140 | ||||||||||||||||||||||
CCDS | CCDS11499 | ||||||||||||||||||||||
HPRD | 01142 | ||||||||||||||||||||||
IMGT | |||||||||||||||||||||||
EMBL | AC004139 AC010792 AC217771 AC217779 AF027491 AF027492 AF027493 AF027494 AF027495 AF027496 AF047856 AF047857 AF047858 AF047859 AF047860 AF047861 AF047862 AF047863 AY526356 AY730549 BC000558 BC098281 BC099721 BC101936 BC114504 BC114948 BN000503 BT006772 CH471233 J03778 M25298 X14474 | ||||||||||||||||||||||
GenPept | AAA57264 AAA60615 AAC04277 AAC04278 AAC04279 AAH00558 AAH98281 AAH99721 AAI01937 AAI14505 AAI14949 AAP35418 AAS17881 AAU45390 CAA32636 CAG26750 EAW93567 EAW93569 | ||||||||||||||||||||||